Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Arran Babbs

Head of Operations, Jenner Vaccine Trials

Senior Leader, Centre for Clinical Vaccinology and Tropical Medicine (CCVTM)

I oversee day-to-day operations at CCVTM working within the senior leadership team, ensuring resource and capacity for us to run and deliver Phase I and Phase II clinical trials of candidate vaccines targeting tuberculosis, malaria, hepatitis C virus, HIV, Ebola, Influenza, emerging and outbreak pathogens.

The Jenner Phase I vaccine trials assess vaccine safety and immunogenicity in health volunteers with Phase II trials assessing vaccine efficacy. Our Phase III COVID-19 and malaria vaccine trials help to support licensing applications.

The Jenner Vaccine Trials team is part of the Primary Care and Vaccines Collaborative Clinical Trials Unit (PCVC-CTU). 

Prior to working at the Jenner I managed a large portfolio of Phase II-IV trials in a wide range of liver and inflammatory bowel diseases at the JR Hospital. I spent the first 16 years of my career working in the laboratory under Professor Dame Kay Davies researching viral vector delivery of small RNAs to induce exon skipping as well as undertaking in vivo trials of small compounds as therapy for Duchenne Muscular Dystrophy.